Kiri Industries: revenue +55% YoY, but PAT surge mostly one-off treasury gains, not ops
PAT +2768% YoY · revenue +54.5% · margins expanding
₹312.36 Cr
+54.5% YoY
₹270.02 Cr
+2768% YoY
45.13%
+40.9pp YoY
₹44.89
Kiri Industries' consolidated revenue from operations came in at ₹312.36 Cr in Q1FY27, up 55% YoY and 25% QoQ, on realisation-led pricing gains across Reactive Dyes, Vinyl Sulphone, H-Acid and basic chemicals rather than volume growth. Consolidated net profit including the ₹20.68 Cr share of profit from JV Lonsen Kiri (Ind-AS bottom line) was ₹290.70 Cr against ₹10.14 Cr a year ago; management's own release headlines operating PAT excluding the associates' share at ₹270.02 Cr. The scale of that swing is overwhelmingly a function of ₹285.93 Cr of 'other income' — per the company's own note, largely the reversal of a non-cash financial transaction from the prior quarter plus quarter-end mark-to-market gains on treasury deployment — rather than the core dyes and chemicals business. Standalone tells the same story: revenue of ₹295.32 Cr (+63% YoY) and PAT of ₹270.24 Cr, with ₹284.13 Cr of total income coming from other income.
Q1 FY-2027 vs prior quarters
Stripped of other income, consolidated EBITDA was ~₹15.9 Cr against a ~₹16.2 Cr loss in Q1FY26 — a genuine but modest operating turnaround, consistent with management's own note that 'core operating EBITDA was positive, as against negative contributions in both Q4FY26 and Q1FY26.' Standalone material margin, the cleanest read on core pricing power, expanded to 31.9% from 23.5% YoY and 20.4% QoQ (₹94.17 Cr), as average selling-price gains for H-Acid and Vinyl Sulphone outran a 41% YoY rise in standalone operating expenses (largely fuel, freight and logistics tied to elevated crude and geopolitical disruption). Finance costs fell sharply — consolidated ₹1.37 Cr versus ₹59.54 Cr a year ago — after subsidiary Claronex Holdings repaid its borrowings, leaving the Group substantially free of external debt, a real and sustainable tailwind distinct from the treasury gains.
The stock went into the print at ₹437, up 9.5% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
Management is deploying the ~$689M DyStar settlement proceeds into a transformative INR 12,000-13,000 crore copper and fertilizer project, forgoing near-term dividends for long-term growth. Phase 1 of the copper project is targeted to be operational by April 2027, projecting INR 20,000-25,000 crore in revenue and INR 1
— This quarter: met
No verifiable third-party consensus estimates for the quarter turned up in search, so the print cannot be benchmarked against Street expectations. Management has not issued formal quarterly PAT or revenue guidance; the only forward commitment on record is last quarter's plan to deploy the ~$689M DyStar settlement into a ₹12,000-13,000 Cr integrated copper and fertilizer complex, targeting Phase 1 by April 2027 with debt financial closure by March 2026. This release confirms the project moved from design into a 'structured construction phase' during the quarter, with the Copper Tube Plant now targeted for Q1FY28, Copper Rod Plant Q2FY28 and Copper Refinery Q4FY28 — broadly consistent with the previously stated timeline — though the filing does not explicitly reconfirm that debt financial closure was achieved. The quarter's other corporate action was the preferential allotment of 51,45,446 equity shares to the promoter group on warrant conversion.
W1
Core EBITDA ex-other-income was only ~₹15.9 Cr this quarter vs a ~₹16.2 Cr loss in Q1FY26 — watch whether it holds without the ₹285.93 Cr other-income boost.
W2
Financial closure for the ₹12,000-13,000 Cr copper-fertilizer project debt funding, guided for March 2026, is not explicitly reconfirmed in this filing.
W3
Copper Tube Plant commissioning targeted Q1FY28 — the first concrete milestone on the phased copper complex to track next.
Clear machine-generated PDF; both statements reconcile exactly to the lakh (totalIncome = revenue+otherIncome; PAT = PBT-tax). Consolidated profitAfterTax above is Ind-AS line 'PAT (7-8)' (₹270.02 Cr), matching management's own headlined PAT and the direct PBT-tax check. The true consolidated bottom line including the ₹20.68 Cr share of associates/JV profit (Ind-AS line 11) is ₹290.70 Cr — this is the figure comparable to the prior DB record of ₹10.14 Cr for Q1FY26 (matches to 4 decimals) and is what YoY/QoQ PAT % below are computed against. ~₹286 Cr of consolidated other income (treasury/mark-to-market gains, per management's own note) dominates the YoY PAT swing; core EBITDA ex-other-income moved from -₹16.2 Cr (Q1FY26) to +₹15.9 Cr (Q1FY27). Q4FY26 comparative PAT was inflated by a ~₹595 Cr one-off deferred tax credit, making QoQ PAT comparison not meaningful. Company allotted 51,45,446 equity shares to promoters on warrant conversion during the quarter, taking paid-up capital to ₹65.17 Cr.
Informational and educational content only. Not investment advice.